BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 205 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $714,000 | -9.5% | 8,112 | 0.0% | 0.01% | -11.1% |
| Q1 2021 | $789,000 | -12.2% | 8,112 | +1.2% | 0.01% | -18.2% |
| Q4 2020 | $899,000 | +19.7% | 8,012 | -1.1% | 0.01% | +10.0% |
| Q3 2020 | $751,000 | -74.3% | 8,100 | -78.3% | 0.01% | -75.6% |
| Q2 2020 | $2,918,000 | +33.4% | 37,400 | 0.0% | 0.04% | +17.1% |
| Q1 2020 | $2,188,000 | -30.3% | 37,400 | -2.1% | 0.04% | +12.9% |
| Q4 2019 | $3,140,000 | +11.1% | 38,200 | -0.7% | 0.03% | 0.0% |
| Q3 2019 | $2,827,000 | -22.1% | 38,475 | 0.0% | 0.03% | -20.5% |
| Q2 2019 | $3,630,000 | +16.0% | 38,475 | -1.6% | 0.04% | +14.7% |
| Q1 2019 | $3,130,000 | +47.2% | 39,092 | -0.9% | 0.03% | +25.9% |
| Q4 2018 | $2,126,000 | -30.9% | 39,435 | 0.0% | 0.03% | -10.0% |
| Q3 2018 | $3,078,000 | +4297.1% | 39,435 | +3485.0% | 0.03% | +2900.0% |
| Q2 2018 | $70,000 | -30.7% | 1,100 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $101,000 | -41.6% | 1,100 | -52.2% | 0.00% | -50.0% |
| Q4 2017 | $173,000 | – | 2,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |